- D69.1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM D69.1 became effective on October 1, 2022.
- This is the American ICD-10-CM version of D69.1 – other international versions of ICD-10 D69.1 may differ.
ICD-10-CM D69.1 is grouped within Diagnostic Related Group(s):
- 813 Coagulation disorders
Applicable To
- Bernard-Soulier [giant platelet] syndrome
- Glanzmann’s disease
- Grey platelet syndrome
- Thromboasthenia (hemorrhagic) (hereditary)
- Thrombocytopathy
Type 1 Excludes
- hemolytic-uremic syndrome (D59.3-)
Type 2 Excludes
- von Willebrand disease (D68.0-)
Code History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2016 (effective 10/1/2015): No change
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2024 (effective 10/1/2022): No change
Diagnosis Index entries containing back-references to D69.1:
- platelets, qualitative > Defect, defective Q89.9
- platelet NEC > Deficiency, deficient
- Bernard-Soulier (thrombopathy) > Disease, diseased
- Glanzmann\’s (hereditary hemorrhagic thrombasthenia) > Disease, diseased
- Naegeli\’s > Disease, diseased
- platelets > Disorder (of)
- platelets > Dysfunction
- giant platelet (Bernard-Soulier) > Syndrome
- platelet > gray or grey (newborn) P93.0